PLUG POWER INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that PLUG POWER INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $709.92M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $628.81M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $891.34M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $701.44M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $502.34M | Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | ($309.10M) | Mar 14, 2022 |
| FY2020 | Sep 30, 2020 | $107.05M | Mar 14, 2022 |
| FY2020 | Jun 30, 2020 | $68.00M | Mar 14, 2022 |
| FY2020 | Mar 31, 2020 | $40.82M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $91.61M | Mar 14, 2022 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $31.87M | Mar 12, 2018 |
| FY2017 | Sep 30, 2017 | $35.37M | Mar 12, 2018 |
| FY2017 | Jun 30, 2017 | $20.78M | Mar 12, 2018 |
| FY2017 | Mar 31, 2017 | $15.24M | Mar 12, 2018 |
| FY2017 | Dec 31, 2016 | $85.93M | Mar 12, 2018 |
| FY2017 | Dec 31, 2015 | $103.29M | Mar 12, 2018 |
| FY2012 | Dec 31, 2012 | $5.7K | Apr 1, 2013 |
| FY2012 | Sep 30, 2012 | $4.3K | Apr 1, 2013 |
| FY2012 | Jun 30, 2012 | $7.2K | Apr 1, 2013 |
| FY2012 | Mar 31, 2012 | $7.2K | Apr 1, 2013 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($242.04M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($624.89M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | ($507.79M) | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | ($194.36M) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | ($171.31M) | Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | ($431.11M) | Mar 14, 2022 |
| FY2020 | Sep 30, 2020 | ($28.58M) | Mar 14, 2022 |
| FY2020 | Jun 30, 2020 | ($15.0K) | Mar 14, 2022 |
| FY2020 | Mar 31, 2020 | ($9.70M) | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $7.75M | Mar 14, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.63B) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($2.10B) | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | ($1.37B) | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | ($724.01M) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | ($459.97M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | ($596.16M) | Mar 1, 2023 |
| FY2020 | Sep 30, 2020 | ($65.22M) | Mar 14, 2022 |
| FY2020 | Jun 30, 2020 | ($9.40M) | Mar 14, 2022 |
| FY2020 | Mar 31, 2020 | ($37.43M) | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | ($18.04M) | Mar 14, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.47B) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($2.02B) | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | ($1.34B) | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | ($679.55M) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | ($437.32M) | Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | ($477.77M) | Mar 14, 2022 |
| FY2020 | Sep 30, 2020 | ($54.31M) | Mar 14, 2022 |
| FY2020 | Jun 30, 2020 | ($26.53M) | Mar 14, 2022 |
| FY2020 | Mar 31, 2020 | ($25.59M) | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | ($7.11M) | Mar 14, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $57.96M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $77.23M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $113.75M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $99.58M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $64.76M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $27.85M | Mar 1, 2023 |
| FY2020 | Sep 30, 2020 | $7.39M | Mar 14, 2022 |
| FY2020 | Jun 30, 2020 | $4.87M | Mar 14, 2022 |
| FY2020 | Mar 31, 2020 | $4.77M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $4.88M | Mar 14, 2022 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $379.57M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $376.11M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $422.47M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $363.93M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $179.85M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $79.35M | Mar 1, 2023 |
| FY2020 | Sep 30, 2020 | $17.21M | May 14, 2021 |
| FY2020 | Jun 30, 2020 | $21.64M | May 14, 2021 |
| FY2020 | Mar 31, 2020 | $11.11M | May 14, 2021 |
| FY2020 | Dec 31, 2019 | $9.97M | May 14, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($535.84M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($728.64M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | ($1.11B) | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | ($828.62M) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | ($358.18M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | ($155.48M) | Mar 1, 2023 |
| FY2020 | Sep 30, 2020 | ($156.51M) | Mar 14, 2022 |
| FY2020 | Jun 30, 2020 | ($111.89M) | Mar 14, 2022 |
| FY2020 | Mar 31, 2020 | ($60.40M) | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | ($53.32M) | Mar 14, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $111.16M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $287.10M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $665.21M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $436.61M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $172.17M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $22.53M | Mar 1, 2023 |
| FY2020 | Sep 30, 2020 | $11.27M | Mar 14, 2022 |
| FY2020 | Jun 30, 2020 | $5.01M | Mar 14, 2022 |
| FY2020 | Mar 31, 2020 | $2.51M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $5.68M | Mar 14, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.59B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $3.60B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $4.90B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $5.76B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $5.95B | Mar 1, 2023 |
| FY2020 | Dec 31, 2020 | $2.25B | Mar 14, 2022 |
| FY2020 | Sep 30, 2020 | $1.36B | Mar 14, 2022 |
| FY2020 | Jun 30, 2020 | $898.72M | Mar 14, 2022 |
| FY2020 | Mar 31, 2020 | $631.36M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $659.51M | Mar 14, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.59B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $1.80B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $2.00B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $1.70B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.34B | Mar 1, 2023 |
| FY2020 | Dec 31, 2020 | $784.36M | Mar 14, 2022 |
| FY2020 | Sep 30, 2020 | $769.83M | Mar 14, 2022 |
| FY2020 | Jun 30, 2020 | $664.16M | Mar 14, 2022 |
| FY2020 | Mar 31, 2020 | $526.26M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $528.46M | Mar 14, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $978.07M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $1.73B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $2.90B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $4.06B | Feb 29, 2024 |
| FY2023 | Dec 31, 2021 | $4.61B | Feb 29, 2024 |
| FY2023 | Dec 31, 2020 | $1.47B | Feb 29, 2024 |
| FY2020 | Sep 30, 2020 | $586.27M | Mar 14, 2022 |
| FY2020 | Jun 30, 2020 | $234.56M | Mar 14, 2022 |
| FY2020 | Mar 31, 2020 | $104.39M | Mar 14, 2022 |
| FY2022 | Dec 31, 2019 | $129.90M | Mar 1, 2023 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $0 | Mar 3, 2025 |
| FY2024 | Dec 31, 2023 | $0 | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $248.61M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $220.44M | Mar 1, 2023 |
| FY2020 | Dec 31, 2020 | $72.39M | Mar 14, 2022 |
| FY2020 | Sep 30, 2020 | $71.82M | Mar 14, 2022 |
| FY2020 | Jun 30, 2020 | $70.26M | Mar 14, 2022 |
| FY2020 | Mar 31, 2020 | $8.67M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $8.84M | Mar 14, 2022 |
| FY2020 | Sep 30, 2019 | $8.61M | Mar 14, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($8.23B) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($6.59B) | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | ($4.49B) | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | ($3.12B) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($2.40B) | Mar 1, 2023 |
| FY2022 | Jan 1, 2021 | $9.60M | Mar 1, 2023 |
| FY2020 | Dec 31, 2020 | ($1.95B) | Mar 14, 2022 |
| FY2020 | Sep 30, 2020 | ($1.46B) | Mar 14, 2022 |
| FY2020 | Jun 30, 2020 | ($1.40B) | Mar 14, 2022 |
| FY2020 | Mar 31, 2020 | ($1.39B) | Mar 14, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $368.54M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $205.69M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $135.03M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $690.63M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $2.48B | Mar 1, 2023 |
| FY2020 | Dec 31, 2020 | $1.31B | Mar 14, 2022 |
| FY2020 | Sep 30, 2020 | $448.14M | Mar 14, 2022 |
| FY2020 | Jun 30, 2020 | $152.49M | Mar 14, 2022 |
| FY2020 | Mar 31, 2020 | $74.34M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $139.50M | Mar 14, 2022 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $3.90M | Feb 29, 2024 |
| FY2022 | Dec 31, 2022 | $9.00M | Mar 1, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | (2) | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | (2) | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | (1) | Mar 14, 2022 |
| FY2020 | Sep 30, 2020 | 0 | Mar 14, 2022 |
| FY2020 | Jun 30, 2020 | 0 | Mar 14, 2022 |
| FY2020 | Mar 31, 2020 | 0 | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 14, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | (2) | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | (2) | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | (1) | Mar 14, 2022 |
| FY2020 | Sep 30, 2020 | 0 | Mar 14, 2022 |
| FY2020 | Jun 30, 2020 | 0 | Mar 14, 2022 |
| FY2020 | Mar 31, 2020 | 0 | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 14, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | 590.35M | Mar 1, 2023 |
| FY2022 | Dec 31, 2021 | 577.65M | Mar 1, 2023 |
| FY2020 | Dec 31, 2020 | 458.05M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | 303.38M | Mar 14, 2022 |
| FY2019 | Dec 31, 2018 | 219.16M | Mar 10, 2020 |
| FY2018 | Dec 31, 2017 | 228.49M | Mar 13, 2019 |
| FY2017 | Dec 31, 2016 | 191.14M | Mar 12, 2018 |
| FY2016 | Dec 31, 2015 | 180.09M | Mar 10, 2017 |
| FY2015 | Dec 31, 2014 | 173.27M | Mar 15, 2016 |
| FY2014 | Dec 31, 2013 | 106.19M | Mar 17, 2015 |